| Guava Technologies recently hired Tefen USA, an operations management consulting firm, to conduct an operational assessment of Guava’s PCA system, a benchtop microcapillary cytometry system for single-cell analysis using fluorescence detection methods.
The assessment analyzed the performance of the PCA in comparison with traditional methods of conducting cell counting to identify benefits that may be expected by a company or lab switching to the use of a PCA and mainly to determine the return on investment (ROI) of the system. For that purpose Tefen has developed an Excel based ROI model and populated it with data collected as part of this study. The model identifies the operational cost of the PCA and the ROI based on company specific inputs such as the number of samples tested, the cost of labor, and other testing parameters. |
